Concurrent Investment Advisors’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.2M Buy
164,960
+15,867
+11% +$2.36M 0.22% 90
2026
Q1
$21.9M Buy
149,093
+12,626
+9% +$1.95M 0.24% 88
2025
Q4
$21.1M Buy
136,467
+53,225
+64% +$7.97M 0.24% 85
2025
Q3
$11.6M Sell
83,242
-41,829
-33% -$5.66M 0.2% 105
2025
Q2
$16.9M Sell
125,071
-23,144
-16% -$3.13M 0.33% 63
2025
Q1
$21.6M Buy
148,215
+31,710
+27% +$4.61M 0.53% 35
2024
Q4
$16M Sell
116,505
-3,558
-3% -$521K 0.43% 48
2024
Q3
$18.5M Sell
120,063
-1,106
-0.9% -$168K 0.55% 35
2024
Q2
$17.7M Sell
121,169
-2,778
-2% -$398K 0.58% 34
2024
Q1
$18.3M Buy
123,947
+9,499
+8% +$1.36M 0.74% 26
2023
Q4
$15.6M Buy
+114,448
New +$14.9M 0.74% 24

Other funds holding XLV

Concurrent Investment Advisors's XLV Position: Q2 2026 in Review

Concurrent Investment Advisors increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 11% in Q2 2026, buying an estimated $2.36M and bringing the position to 164,960 shares worth $26.2M. The position accounts for 0.22% of the portfolio, ranked #90.

Concurrent Investment Advisors first reported a position in XLV in Q4 2023 and has held it in 11 quarters since. 1,852 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Concurrent Investment Advisors held 164,960 shares of State Street Health Care Select Sector SPDR ETF worth $26.2M as of Q2 2026.
  • Concurrent Investment Advisors bought 15,867 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $2.36M.
  • State Street Health Care Select Sector SPDR ETF made up 0.22% of Concurrent Investment Advisors's portfolio in Q2 2026, its #90 holding.
  • Concurrent Investment Advisors first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2023 and has held it in 11 quarters since.
  • 1,852 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.